APYX vs REG · rev $48.1M vs P/E 34, $12.93B cap
Apyx Medical Inc (APYX) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
REG does not have a complete income-statement cache yet.
APYX currently screens at market cap $179.6M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the APYX and REG stock pages for the full models.
Not investment advice.